NCT00822848 2018-09-07Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue SarcomaOHSU Knight Cancer InstitutePhase 1 Completed18 enrolled